
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biosci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Biosci. Rep</journal-id><journal-id journal-id-type="hwp">ppbioscirep</journal-id><journal-id journal-id-type="publisher-id">BSR</journal-id><journal-title-group><journal-title>Bioscience Reports</journal-title></journal-title-group><issn pub-type="ppub">0144-8463</issn><issn pub-type="epub">1573-4935</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29437902</article-id><article-id pub-id-type="pmc">5843748</article-id><article-id pub-id-type="doi">10.1042/BSR20171741</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>46</subject><subject>7</subject><subject>43</subject><subject>41</subject></subj-group></article-categories><title-group><article-title>Maternal resveratrol consumption and its programming effects on metabolic health in offspring mechanisms and potential implications</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Sheng</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="author-notes" rid="afn1">*</xref></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Qianyun</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref><xref ref-type="author-notes" rid="afn1">*</xref></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Jia</given-names></name><xref ref-type="aff" rid="A4"><sup>4</sup></xref><xref ref-type="corresp" rid="COR1"/></contrib><aff id="A1"><label>1</label>Tianjin University of Traditional Chinese Medicine, Tianjin, China</aff><aff id="A2"><label>2</label>Department of Pediatrics, The Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China</aff><aff id="A3"><label>3</label>The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Shandong University Qilu Hospital, Shandong, China</aff><aff id="A4"><label>4</label>Department of Endocrinology, Peking University First Hospital, Beijing, China</aff></contrib-group><author-notes><corresp id="COR1"><bold>Correspondence:</bold> Jia Zheng (<email>zhengjiapumc@163.com</email>)</corresp><fn id="afn1" fn-type="equal"><label>*</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epreprint"><day>30</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>09</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><day>27</day><month>4</month><year>2018</year></pub-date><volume>38</volume><issue>2</issue><elocation-id>BSR20171741</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2017</year></date><date date-type="rev-recd"><day>27</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 The Author(s).</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bsr-38-bsr20171741.pdf"/><abstract><p>A growing body of evidence has clearly demonstrated that maternal nutrition can strongly determine the susceptibility to the development of metabolic diseases in offspring. With the increasing prevalence of maternal overweight, obesity, and gestational diabetes mellitus, it yields enormous burden for individual and public health. Interventions during pregnancy have been proven to be challenging, with limited efficacy and low compliance. Resveratrol, as a natural polyphenolic compound, has a wide-range of beneficial properties, including potent antiobesogenic, antiatherosclerotic, and antidiabetic effects. However, the role of maternal resveratrol intake on metabolic health in offspring has not been extensively investigated. Therefore, the aim of this study was to review the effects of maternal resveratrol supplementation on metabolic health in offspring and its potential mechanisms.</p></abstract><kwd-group><kwd>cardiometabolic health</kwd><kwd>offspring</kwd><kwd>pregnancy</kwd><kwd>Resveratrol consumption</kwd></kwd-group><counts><page-count count="9"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>The incidence of obesity and diabetes is increasing rapidly, placing a huge economic burden on society [<xref rid="B1" ref-type="bibr">1</xref>]. However, the pathogenesis of diabetes has not been fully illustrated. Emerging data show that perinatal nutrition consumption is a pivotal factor determining the susceptibility to metabolic disorders [<xref rid="B2" ref-type="bibr">2&#x02013;4</xref>]. In particular, approximately one in six births is affected by gestational diabetes mellitus (GDM) reported by International Diabetes Federation Atlas in late 2017 [<xref rid="B1" ref-type="bibr">1</xref>]. The World Health Organization newly reported that 50% of women of childbearing ages, and 20&#x02013;25% of pregnant women in Europe were affected by overweight or obesity [<xref rid="B5" ref-type="bibr">5</xref>]. As demonstrated by the &#x0201c;Developmental Origins of Health and Disease (DOHaD)&#x0201d; theory [<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>], obese mothers and women with GDM are associated with infant weight <italic>z</italic>-scores at birth and at 6 months [<xref rid="B8" ref-type="bibr">8</xref>], childhood obesity [<xref rid="B9" ref-type="bibr">9</xref>], and unhealthy body composition in adult offspring [<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>]. They are more likely to develop insulin resistance [<xref rid="B12" ref-type="bibr">12</xref>], type 2 diabetes [<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>] and even early childhood type 1 diabetes [<xref rid="B15" ref-type="bibr">15</xref>], and cardiovascular diseases [<xref rid="B16" ref-type="bibr">16</xref>] in adulthood.</p></sec><sec id="sec2"><title>Interventions for metabolic health during pregnancy are limited</title><p>With the increasing prevalence of metabolic diseases during pregnancy, such as maternal obesity and GDM, it yields enormous burden for individual and public health [<xref rid="B17" ref-type="bibr">17</xref>]. Preventing obesity, insulin resistance, and type 2 diabetes during pregnancy has pronounced benefits [<xref rid="B18" ref-type="bibr">18</xref>]. Lifestyle interventions, including diet and exercise, have been widely used to prevent and treat abnormal metabolism during pregnancy [<xref rid="B19" ref-type="bibr">19</xref>]. However, it has proven to be challenging, with limited efficacy and low compliance. One meta-analysis indicated that diet and lifestyle interventions in pregnancy were able to reduce gestational weight gain; however, no effects on composite maternal and fetal outcomes were observed [<xref rid="B20" ref-type="bibr">20</xref>]. Poston et al. [<xref rid="B21" ref-type="bibr">21</xref>] showed that a behavioral intervention with diet and physical activity in obese mothers was insufficient to reduce the incidence of fetal macrosomia or to prevent GDM occurrence. Han et al. [<xref rid="B22" ref-type="bibr">22</xref>] showed that for women with GDM, there were no differences in adverse pregnancy outcomes among several kinds of dietary advice. Flynn et al. [<xref rid="B23" ref-type="bibr">23</xref>] showed that the methodological variability in dietary interventions to control gestational weight gain in pregnant women was large, which limited the ability to apply the evidence in clinical practice and develop clinical guidelines. Other management practices, such as medication therapy for GDM, are expensive and with side effects [<xref rid="B24" ref-type="bibr">24</xref>]. Therefore, alternative interventions for metabolic health during pregnancy are needed.</p></sec><sec id="sec3"><title>Historical perspective of active compounds isolated from plants and herbs</title><p>Traditional Chinese Medicine (TCM), as an herbal medicine with a 2000-year-old history, has been widely used to treat diseases in most Asian countries [<xref rid="B25" ref-type="bibr">25</xref>]. The safety, efficacy, and mechanisms of most TCM have been clearly demonstrated, and compounds from dietary plants and herbs have been widely used in complementary and alternative medicine [<xref rid="B26" ref-type="bibr">26</xref>]. For example, artemisinin, as an important antimalarial drug, is mainly discovered and isolated from sweet wormwood [<xref rid="B27" ref-type="bibr">27</xref>]. In addition, approximately 50% of pharmaceutical drugs may be plant derivatives [<xref rid="B28" ref-type="bibr">28</xref>]. Salicylic acid, isolated from the willow tree, is the basis of the common drug, aspirin. Atropine, as a muscle relaxant, is isolated from nightshade plants, and morphine is extracted from the opium poppy [<xref rid="B29" ref-type="bibr">29</xref>]. In recent years, active compounds isolated from plants and herbs have been discovered, due to its multiple therapeutic capacities [<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B30" ref-type="bibr">30</xref>].</p></sec><sec id="sec4"><title>Resveratrol and its roles in human health</title><p>Resveratrol, a polyphenolic compound (3,4&#x02032;,5-trihydroxystilbene), is mostly isolated from grapes (<xref ref-type="fig" rid="F1">Figure 1</xref>). It also naturally presents in a variety of plant foods such as peanuts and cranberries [<xref rid="B31" ref-type="bibr">31</xref>]. It indicates that resveratrol has a variety of beneficial health effects, such as anti-inflammatory [<xref rid="B32" ref-type="bibr">32</xref>], antioxidant [<xref rid="B33" ref-type="bibr">33</xref>], and anticarcinogenic [<xref rid="B34" ref-type="bibr">34</xref>] properties. Resveratrol also can ameliorate metabolic diseases [<xref rid="B35" ref-type="bibr">35</xref>], including cardioprotective, antiobesogenic [<xref rid="B30" ref-type="bibr">30</xref>], antiatherosclerotic [<xref rid="B36" ref-type="bibr">36</xref>], and antidiabetic [<xref rid="B37" ref-type="bibr">37</xref>] effects. A systematic analysis of 21 studies found that daily resveratrol consumption (&#x02265;300 mg/day) significantly reduced blood pressure, total cholesterol, and plasma glucose in obese subjects, with lower risks of cardiovascular diseases [<xref rid="B38" ref-type="bibr">38</xref>]. However, evidence about the effects of maternal resveratrol intake on metabolic health in offspring is limited. Therefore, we aimed to review the effects of maternal resveratrol consumption on metabolic health in offspring and its potential mechanisms underlying these programming effects.</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>The molecular structure of resveratrol isolated from grapes</title><p>Resveratrol, a polyphenolic compound (3,4&#x02032;,5-trihydroxystilbene), is mostly present in grapes. Resveratrol has a variety of beneficial health effects and exhibits several biological properties, including its cardioprotective, antiobesogenic, antiatherosclerotic, and antidiabetic effects.</p></caption><graphic xlink:href="bsr-38-bsr20171741-g1"/></fig></sec><sec id="sec5"><title>Maternal resveratrol consumption and metabolic health</title><sec id="sec5-1"><title>Evidence from clinical studies in human</title><p>The beneficial effects of resveratrol supplementation in humans are widely studied, but the studies about the effects of resveratrol intake during pregnancy on metabolic health in humans are limited. Several studies show that oral resveratrol is well absorbed and rapidly metabolized, without pronounced toxicity [<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref>]. One clinical study was conducted to evaluate the metabolic effects of resveratrol in overweight pregnant women. It showed that resveratrol supplement (80 mg) reduced the incidence of GDM and improved the lipid profile and glucose blood level after 60 days [<xref rid="B41" ref-type="bibr">41</xref>]. It also showed that both the time and doses of blood pressure control were significantly reduced in preeclampsia patients who received resveratrol supplementation (50&#x02009;mg each, up to five dosages) [<xref rid="B42" ref-type="bibr">42</xref>]. It suggested that maternal resveratrol intake has a beneficial effect in pregnant women. However, the evidence is limited and no information is available about the different effects of resveratrol depending on the dietary intake on pregnant women. Thus, more clinical studies with larger sample size are needed.</p></sec><sec id="sec5-2"><title>Evidence from <italic>in vivo</italic> and <italic>in vitro</italic> experiments</title><sec id="sec5-2-1"><title>Maternal resveratrol consumption and glucose metabolism</title><p>Animal experiments showed that maternal resveratrol consumption can improve glucose metabolism in pregnant females, as well as in offspring. Resveratrol supplementation throughout pregnancy was able to decrease maternal body weight, improve glucose tolerance, and increase blood flow volume in uterine artery, with lower triglyceride deposition in liver and decreased placental inflammation in nonhuman primates [<xref rid="B43" ref-type="bibr">43</xref>]. Using a genetic mouse model of GDM, it showed that resveratrol intake (10 mg/kg body weight per day) before pregnancy and during pregnancy significantly alleviated hyperglycemia, improved insulin resistance, increased fetal survival, and decreased body weight at birth. They further found that resveratrol enhanced adenosine monophosphate activated protein kinase (AMPK) activation and reduced glucose-6-phosphatase activity in pregnant C57BL/KsJ-Leptin (db/+) mouse, as well as the offspring [<xref rid="B44" ref-type="bibr">44</xref>]. Using human samples, Lappas et al. [<xref rid="B45" ref-type="bibr">45</xref>] investigated the effects of resveratrol incubation (50, 100, and 200 &#x003bc;mol/l) on insulin resistance and placental inflammation associated with GDM. It showed that resveratrol was able to ameliorate placental inflammation triggered by lipopolysaccharide (LPS), with decreased tumor necrosis factor (TNF), interleukin-6 (IL-6), and interleukin-8 (IL-8) gene expressions in human placentas. Recently, Tran et al. [<xref rid="B46" ref-type="bibr">46</xref>] found that treatment with resveratrol (200 &#x003bc;mol/l) significantly reduced the secretion and expression of proinflammatory cytokines, such as IL-6, interleukin-1&#x003b1; (IL-1&#x003b1;), interleukin-1&#x003b2; (IL-1&#x003b2;), IL-8, and monocyte chemoattractantprotein-1 (MCP-1) in human placenta and adipose tissue. It was able to restore the impaired insulin signaling and glucose uptake activity assessed by radio-labeled assay in skeletal muscles obtained from pregnant individuals. Thus, maternal resveratrol intake had a beneficial effect on glucose metabolism in pregnant females and offspring.</p></sec><sec id="sec5-2-2"><title>Maternal resveratrol consumption and its effects on lipid metabolism</title><p>Maternal resveratrol administration (0.2% diet) in pregnant mice increased energy expenditure and insulin sensitivity, which was associated with increased brown adipose activity and the browning of white adipose tissue [<xref rid="B47" ref-type="bibr">47</xref>]. Maternal resveratrol consumption (50 mg/l in the drinking water) during pregnancy and lactation reduced body weight, serum leptin level, visceral and subcutaneous adipose tissue weight, with females being more affected in offspring rats, indicating sexually dimorphic impact [<xref rid="B48" ref-type="bibr">48</xref>]. Franco et al. [<xref rid="B49" ref-type="bibr">49</xref>] also showed that maternal resveratrol intake (30 mg/kg body weight/day) decreased body weight and fat mass in offspring. It was able to reverse hyperleptinemia and improve hypothalamic leptin signaling. Resveratrol administration (100 mg/kg body weight) from embryonic day 3 to 12 prevented the occurrence of oxidative stress and apoptosis in embryos; it further decreased blood cholesterol level by 41.74% and triglyceride level by 60.64% in diabetic dams [<xref rid="B50" ref-type="bibr">50</xref>]. Thus, it indicated that maternal resveratrol intake was able to improve lipid metabolism in both dams and offspring.</p></sec><sec id="sec5-2-3"><title>Maternal resveratrol consumption and its effects on cardiovascular function</title><p>Maternal resveratrol supplementation (4 g/kg diet) during pregnancy and lactation alleviated the development of hypertension in adult offspring, with improved nitric oxide bioavailability in spontaneously hypertensive rats [<xref rid="B51" ref-type="bibr">51</xref>]. However, Moraloglu et al. [<xref rid="B52" ref-type="bibr">52</xref>] found that resveratrol intake (20&#x02009;mg/kg per day) during the whole pregnancy did not decrease blood pressure, and did not result in a significant response in blood flows and placental pathology parameters in pregnant rats. Resveratrol consumption (4 g/kg diet) improved cardiac recovery from ischemia/reperfusion injury and attenuated superoxide levels in both male and female rat offspring exposed to prenatal hypoxia [<xref rid="B53" ref-type="bibr">53</xref>]. This variability in findings could be caused by variations in the different doses of resveratrol intake or the length of study duration. Thus, it suggests that the efficacy of distinct doses is needed to be evaluated and the best dosing should be determined in further studies. The relevant evidence of maternal resveratrol intake and metabolic health in both pregnant females and offspring are summarized in <xref ref-type="table" rid="T1">Table 1</xref>.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Relevant studies about maternal resveratrol intake and metabolic health in offspring</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Resveratrol consumption</th><th align="left" rowspan="1" colspan="1">Intervention period</th><th align="left" rowspan="1" colspan="1">Species</th><th align="left" rowspan="1" colspan="1">Beneficial effects on pregnant females</th><th align="left" rowspan="1" colspan="1">Beneficial effects on offspring</th><th align="left" rowspan="1" colspan="1">Potential mechanism</th><th align="left" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">A Western-style diet supplemented with 0.37% resveratrol</td><td rowspan="3" colspan="1">Throughout pregnancy</td><td rowspan="3" colspan="1">Nonhuman primates</td><td rowspan="1" colspan="1">- Resulted in maternal weight loss and improved glucose tolerance</td><td rowspan="1" colspan="1">- Fetal pancreatic mass was enlarged by 42%</td><td rowspan="3" colspan="1">May be driven by an eNOS-dependent mechanism</td><td rowspan="3" colspan="1">Roberts et al. [<xref rid="B43" ref-type="bibr">43</xref>]</td></tr><tr><td rowspan="1" colspan="1">- Increased uterine artery volume blood flow</td><td rowspan="1" colspan="1">- A 12-fold increase in proliferation</td></tr><tr><td rowspan="1" colspan="1">- Decreased placental inflammation and liver triglyceride deposition</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Oral gavage with resveratrol (10 mg/kg body weight per day)</td><td rowspan="2" colspan="1">Four weeks before pregnancy and during pregnancy</td><td rowspan="2" colspan="1">A genetic GDM model: C57BL/KsJ-Leptin (db/+) mouse</td><td rowspan="2" colspan="1">- Improved glucose metabolism, insulin tolerance, and reproductive outcome of the pregnant db/+ females</td><td rowspan="2" colspan="1">- Increased fetal survival and decreased body weight</td><td rowspan="1" colspan="1">- Enhanced AMPK activation</td><td rowspan="2" colspan="1">Yao et al. [<xref rid="B44" ref-type="bibr">44</xref>]</td></tr><tr><td rowspan="1" colspan="1">- Reduced production and activity of G6Pase</td></tr><tr><td rowspan="1" colspan="1">50, 100, and 200 &#x003bc;mol/l resveratrol incubation</td><td rowspan="1" colspan="1">6- and/or 24-h incubation</td><td rowspan="1" colspan="1">Human placenta</td><td rowspan="1" colspan="1">- Quenched inflammation induced by LPS</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">- SIRT1 possessed anti-inflammatory actions</td><td rowspan="1" colspan="1">Lappas et al. [<xref rid="B45" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="1" colspan="1">200 &#x003bc;mol/l resveratrol incubation</td><td rowspan="1" colspan="1">20-h incubation</td><td rowspan="1" colspan="1">Human placenta, adipose tissue, and skeletal muscle</td><td rowspan="1" colspan="1">- Reduced the expression and secretion of pro-inflammatory cytokines IL-6, IL-1&#x003b1;, IL-1&#x003b2;, IL-8, and MCP-1 in human placenta and omental and subcutaneous adipose tissue</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">- Restored the impaired insulin signaling pathway and insulin-mediated glucose uptake in human skeletal muscle</td><td rowspan="1" colspan="1">Tran et al. [<xref rid="B46" ref-type="bibr">46</xref>]</td></tr><tr><td rowspan="2" colspan="1">A high-fat diet with or without 0.2% (w/w) resveratrol</td><td rowspan="2" colspan="1">During pregnancy and lactation</td><td rowspan="2" colspan="1">C57BL/6 J mice</td><td rowspan="1" colspan="1">- Protected dams against body weight gain and fat accumulation</td><td rowspan="1" colspan="1">- Increased energy expenditure and insulin sensitivity</td><td rowspan="2" colspan="1">- Increased phosphorylated AMPK&#x003b1; levels, Sirt1, PRDM16, and other thermogenic genes protein contents</td><td rowspan="2" colspan="1">Zou et al. [<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td rowspan="1" colspan="1">- Reduced the concentrations of triglycerides and insulin</td><td rowspan="1" colspan="1">- Enhanced white adipose tissue browning</td></tr><tr><td rowspan="2" colspan="1">Resveratrol (50 mg/l) in drinking water</td><td rowspan="2" colspan="1">During pregnancy and lactation</td><td rowspan="2" colspan="1">Wistar rats</td><td rowspan="2" colspan="1">- No difference in body weight at the end of lactation</td><td rowspan="2" colspan="1">- Reduced body weight, leptin, VAT and SCAT, with females being more affected</td><td rowspan="1" colspan="1">- Decreased fatty acid synthase expression in VAT</td><td rowspan="2" colspan="1">Ros et al. [<xref rid="B48" ref-type="bibr">48</xref>]</td></tr><tr><td rowspan="1" colspan="1">- An antiadipogenic effect</td></tr><tr><td rowspan="1" colspan="1">Resveratrol (30 mg/kg body weight/day)</td><td rowspan="1" colspan="1">8 weeks before mating and throughout gestation and lactation</td><td rowspan="1" colspan="1">Wistar rats</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">- Decreased body weight, subcutaneous and visceral fat mass, and adiposity</td><td rowspan="1" colspan="1">- Increased p-STAT3 content in the hypothalamus</td><td rowspan="1" colspan="1">Franco et al. [<xref rid="B49" ref-type="bibr">49</xref>]</td></tr><tr><td rowspan="2" colspan="1">Resveratrol (100&#x02009;mg/kg body weight) was administered by gavage feeding</td><td rowspan="2" colspan="1">10 days (from day E3 to E12)</td><td rowspan="2" colspan="1">Sprague Dawley rats</td><td rowspan="2" colspan="1">- Decreased lipid accumulation including cholesterol by 41.74% and triglyceride by 60.64% and increased HDL in diabetic dams</td><td rowspan="2" colspan="1">- Prevented both oxidative stress and apoptosis in embryos</td><td rowspan="1" colspan="1">- Stimulation of the extrinsic and intrinsic pathway</td><td rowspan="2" colspan="1">Singh et al. [<xref rid="B50" ref-type="bibr">50</xref>]</td></tr><tr><td rowspan="1" colspan="1">- May attenuate the expression of HMG-CoA reductase</td></tr><tr><td rowspan="1" colspan="1">Resveratrol-supplemented diet (4 g/kg diet)</td><td rowspan="1" colspan="1">From gestational day 0.5 until postnatal day 21</td><td rowspan="1" colspan="1">Spontaneously hypertensive rat</td><td rowspan="1" colspan="1">- Had no effect on blood flow patterns in the maternal uterine arteries</td><td rowspan="1" colspan="1">- Mitigated the development of hypertension in adult offspring</td><td rowspan="1" colspan="1">- Improved nitric oxide bioavailability</td><td rowspan="1" colspan="1">Care et al. [<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td rowspan="2" colspan="1">20&#x02009;mg/kg per day and twice daily</td><td rowspan="2" colspan="1">During the whole pregnancy</td><td rowspan="2" colspan="1">Wistar albino rats</td><td rowspan="1" colspan="1">- Did not decrease blood pressure</td><td rowspan="2" colspan="1">NA</td><td rowspan="2" colspan="1">NA</td><td rowspan="2" colspan="1">Moraloglu et al. [<xref rid="B52" ref-type="bibr">52</xref>]</td></tr><tr><td rowspan="1" colspan="1">- No changes in blood flows and placental pathology parameters</td></tr><tr><td rowspan="2" colspan="1">Resveratrol supplementation (4 g/kg diet)</td><td rowspan="2" colspan="1">For 9 weeks following weaning</td><td rowspan="2" colspan="1">Sprague&#x02013;Dawley rats</td><td rowspan="2" colspan="1">NA</td><td rowspan="1" colspan="1">- Improved cardiac recovery from ischemia/reperfusion injury</td><td rowspan="2" colspan="1">- Unclear, without AMPK&#x02013;ACC signaling activation</td><td rowspan="2" colspan="1">Shah et al. [<xref rid="B53" ref-type="bibr">53</xref>]</td></tr><tr><td rowspan="1" colspan="1">- Attenuated superoxide levels</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: ACC, acetyl-CoA carboxylase; AMPK, adenosine monophosphate activated protein kinase; E, embryonic; eNOS, endothelial nitric oxide synthase; G6Pase, glucose-6-phosphatase; GDM:, gestational diabetes mellitus; HDL, high-density lipoprotein; HMG-CoA, hydroxy-3-methyl-glutaryl (HMG)-CoA reductase; IL-1&#x003b1;, interleukin-1&#x003b1;; IL-1&#x003b2;, interleukin-1&#x003b2;; IL-6, interleukin-6; IL-8, interleukin-8; LPS, lipopolysaccharide; MCP-1, monocyte chemoattractantprotein-1; NA, not available; PRDM16, PR domain containing 16; p-STAT3, phosphorylated-signal transducer and activator of transcription 3; SCAT, subcutaneous adipose tissue; SIRT, sirtuin; VAT, visceral adipose tissue.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec5-2-4"><title>Possible harmful effects of resveratrol</title><p>In addition to the above beneficial effects of resveratrol, detrimental effects of resveratrol should also be considered. Studies that reported possible harmful effects of resveratrol are limited. Roebrts et al. [<xref rid="B43" ref-type="bibr">43</xref>] found that, in stark contrast with the other seemingly beneficial effects to the placenta and developing fetus, a dramatic increase in fetal pancreatic mass and exocrine proliferation, independent of an increase in islet mass, following maternal resveratrol supplementation in nonhuman primates which is clinically concerning. Klink et al. [<xref rid="B54" ref-type="bibr">54</xref>] showed that resveratrol was associated with significantly worse survival with LAPC-4 (the human CaP cell line) tumors and caution should be advised in using resveratrol for patients. Further studies about other possible harmful effects of resveratrol should be conducted.</p></sec></sec><sec id="sec5-3"><title>Potential mechanisms of maternal resveratrol consumption and metabolic health in offspring</title><p>Taken together, the above studies suggest that maternal resveratrol intake protects against hyperglycemia, insulin resistance, dyslipidemia, and cardiac function in pregnant females, as well as their offspring. However, the molecular mechanisms are not clearly elaborated. It is speculated that &#x0201c;developmental programming&#x0201d; may be the underlying mechanism that can elucidate maternal nutrition and metabolic health in offspring [<xref rid="B55" ref-type="bibr">55</xref>]. Several potential points can explain the beneficial effects of maternal resveratrol consumption on offspring, which are summarized in <xref ref-type="fig" rid="F2">Figure 2</xref>. First, resveratrol can decrease inflammation reaction in placental and normalize embryonic oxidative stress level [<xref rid="B43" ref-type="bibr">43</xref>], due to its anti-inflammatory [<xref rid="B32" ref-type="bibr">32</xref>], antioxidant [<xref rid="B33" ref-type="bibr">33</xref>] properties. Second, it can reverse hyperleptinemia and improve hypothalamic leptin signaling in offspring [<xref rid="B49" ref-type="bibr">49</xref>]. Another possible mechanism is epigenetic modification [<xref rid="B56" ref-type="bibr">56</xref>]. Our previous studies showed that epigenetics can link early life nutrition and cardiometabolic health in later life [<xref rid="B57" ref-type="bibr">57&#x02013;60</xref>]. It demonstrated that resveratrol was able to modulate histone H3 on lysine 9 (H3K9) methylation and acetylation in the zygotic pronuclei [<xref rid="B61" ref-type="bibr">61</xref>]. Gestational resveratrol exposure induced breast cancer-1 (BRCA-1) promoter hypermethylation and reduced BRCA-1 expression in mammary tissue of rat offspring [<xref rid="B62" ref-type="bibr">62</xref>]. However, whether the role of maternal resveratrol consumption on the offspring is due to adaptive responses to improved glucose and lipid metabolism in mothers, or is the direct result of resveratrol transfer through the placenta or the mother&#x02019;s milk is still unclear. There have been no reports, however, on whether resveratrol crosses the placental barrier. One study showed that as a polyphenol, administration of resveratrol has vasodilator effect on isolated human umbilical vein <italic>in vitro</italic> [<xref rid="B63" ref-type="bibr">63</xref>]. Jang et al. [<xref rid="B64" ref-type="bibr">64</xref>] showed that resveratrol is beneficial against diabetes-induced embryonic malformation, we therefore might cautiously assume that it does cross the placental barrier. Thus, further studies focusing on this point and the molecular mechanisms in depth are warranted.</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Maternal resveratrol consumption and its beneficial effects on metabolic health in offspring</title><p>It is speculated that &#x0201c;Developmental Programming&#x0201d; is the underlying mechanism because it can link maternal nutrition and metabolic health in offspring. Several potential points could explain the beneficial effects of maternal resveratrol consumption on offspring. First, resveratrol can decrease inflammation reaction in placental and normalized embryonic oxidative stress level, due to its anti-inflammatory and antioxidant properties. Second, it was able to improve hypothalamic leptin signaling in offspring with central nervous system regulation. Another possible mechanism is epigenetic modification, including methylation and acetylation, thus regulate gene expressions.</p></caption><graphic xlink:href="bsr-38-bsr20171741-g2"/></fig></sec></sec><sec sec-type="conclusions" id="sec6"><title>Conclusions</title><p>In summary, pregnancy period is the critical time window of offspring/embryo growth and development. Perinatal nutrition consumption can determine the susceptibility of developing metabolic diseases in adulthood. Interventions during pregnancy are challenging, with limited efficacy and low compliance. Our review suggests that maternal resveratrol consumption during pregnancy has beneficial effects on metabolic health in both pregnant females and offspring. More importantly, the safe and easy implementation of resveratrol consumption has been widely accepted. A broad understanding of the role of resveratrol supplementation during pregnancy can provide critical hints for the early prevention and treatment of metabolic diseases during pregnancy, and thus ensure a healthier future for the mothers and offspring.</p></sec></body><back><sec id="sec7" sec-type="author-contrib"><title>Author Contribution</title><p>S.Z. and Q.Y.F. collected data, synthesized data, and wrote the manuscript. J.C. and J.Z. reviewed and edited the manuscript. J.Z. contributed to the design of this review.</p></sec><sec id="sec8" sec-type="funding"><title>Funding</title><p>This study was sponsored by Beijing Municipal Natural Science Foundation (No. 7184252), the Fund for Fostering Young Scholars of Peking University Health Science Center (No. BMU2017PY008), China Scholarship Council of the Ministry of Education (No. 201506210378), and Postgraduate Student Innovation Fund in Peking Union Medical College (No. 2013-1002-33). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.</p></sec><sec id="sec9" sec-type="COI-statement"><title>Competing Interests</title><p>The authors declare that there are no competing interests associated with the manuscript.</p></sec><glossary><title>Abbreviations</title><def-list list-content="abbreviations"><def-item><term id="G1">AMPK</term><def><p>adenosine monophosphate activated protein kinase</p></def></def-item><def-item><term id="G2">BRCA-1</term><def><p>breast cancer-1</p></def></def-item><def-item><term id="G3">GDM</term><def><p>gestational diabetes mellitus</p></def></def-item><def-item><term id="G4">IL</term><def><p>interleukin</p></def></def-item><def-item><term id="G5">LPS</term><def><p>lipopolysaccharide</p></def></def-item><def-item><term id="G6">MCP-1</term><def><p>monocyte chemoattractantprotein-1</p></def></def-item><def-item><term id="G7">TCM</term><def><p>Traditional Chinese Medicine</p></def></def-item><def-item><term id="G8">TNF</term><def><p>tumor necrosis factor</p></def></def-item></def-list></glossary><ref-list><ref id="B1"><label>1</label><mixed-citation publication-type="other"><comment>International Diabetes Federation. (2017) IDF diabetes atlas, 8th edn <ext-link ext-link-type="uri" xlink:href="http://www.diabetesatlas.org">www.diabetesatlas.org</ext-link></comment></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinhas-Hamiel</surname><given-names>O.</given-names></name> and <name><surname>Zeitler</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>) <article-title>The global spread of type 2 diabetes mellitus in children and adolescents</article-title>. <source>J. Pediatr.</source>
<volume>146</volume>, <fpage>693</fpage>&#x02013;<lpage>700</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2004.12.042</pub-id>
<pub-id pub-id-type="pmid">15870677</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rando</surname><given-names>O.J.</given-names></name> and <name><surname>Simmons</surname><given-names>R.A.</given-names></name></person-group> (<year>2015</year>) <article-title>I&#x02019;m eating for two: parental dietary effects on offspring metabolism</article-title>. <source>Cell</source>
<volume>161</volume>, <fpage>93</fpage>&#x02013;<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.02.021</pub-id>
<pub-id pub-id-type="pmid">25815988</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>N.</given-names></name>, <name><surname>Pasupathy</surname><given-names>D.</given-names></name> and <name><surname>Poston</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>) <article-title>Determining the consequences of maternal obesity for offspring health</article-title>. <source>Exp. Physiol.</source>
<volume>100</volume>, <fpage>1421</fpage>&#x02013;<lpage>1428</lpage>
<pub-id pub-id-type="doi">10.1113/EP085132</pub-id>
<pub-id pub-id-type="pmid">26464224</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><collab>Organization, W.H.</collab> (<year>2016</year>) <article-title>Obesity and overweight</article-title>, <comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/gho/ncd/risk_factors/overweight/en/">http://www.who.int/gho/ncd/risk_factors/overweight/en/</ext-link></comment></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallack</surname><given-names>L.</given-names></name> and <name><surname>Thornburg</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>) <article-title>Developmental origins, epigenetics, and equity: moving upstream</article-title>. <source>Matern. Child Health J.</source>
<volume>20</volume>, <fpage>935</fpage>&#x02013;<lpage>940</lpage>
<pub-id pub-id-type="doi">10.1007/s10995-016-1970-8</pub-id>
<pub-id pub-id-type="pmid">27029539</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>J.</given-names></name>, <name><surname>Jacob</surname><given-names>C.</given-names></name>, <name><surname>Barker</surname><given-names>M.</given-names></name>, <name><surname>Fall</surname><given-names>C.H.</given-names></name>, <name><surname>Hanson</surname><given-names>M.</given-names></name>, <name><surname>Harvey</surname><given-names>N.C.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Developmental origins of health and disease: A lifecourse approach to the prevention of non-communicable diseases</article-title>. <source>Healthcare</source>
<volume>5</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage><pub-id pub-id-type="pmid">28668197</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>N.</given-names></name>, <name><surname>Hellmuth</surname><given-names>C.</given-names></name>, <name><surname>Uhl</surname><given-names>O.</given-names></name>, <name><surname>Godfrey</surname><given-names>K.</given-names></name>, <name><surname>Briley</surname><given-names>A.</given-names></name>, <name><surname>Welsh</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Cord metabolic profiles in obese pregnant women; insights into offspring growth and body composition</article-title>. <source>J. Clin. Endocrinol. Metab.</source>, <volume>103</volume>, <fpage>346</fpage>&#x02013;<lpage>355</lpage></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillier</surname><given-names>T.A.</given-names></name>, <name><surname>Pedula</surname><given-names>K.L.</given-names></name>, <name><surname>Schmidt</surname><given-names>M.M.</given-names></name>, <name><surname>Mullen</surname><given-names>J.A.</given-names></name>, <name><surname>Charles</surname><given-names>M.A.</given-names></name> and <name><surname>Pettitt</surname><given-names>D.J.</given-names></name></person-group> (<year>2007</year>) <article-title>Childhood obesity and metabolic imprinting: The ongoing effects of maternal hyperglycemia</article-title>. <source>Diabetes Care</source>
<volume>30</volume>, <fpage>2287</fpage>&#x02013;<lpage>2292</lpage>
<pub-id pub-id-type="doi">10.2337/dc06-2361</pub-id>
<pub-id pub-id-type="pmid">17519427</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaseva</surname><given-names>N.</given-names></name>, <name><surname>Vaarasmaki</surname><given-names>M.</given-names></name>, <name><surname>Matinolli</surname><given-names>H.M.</given-names></name>, <name><surname>Sipola-Leppanen</surname><given-names>M.</given-names></name>, <name><surname>Tikanmaki</surname><given-names>M.</given-names></name>, <name><surname>Heinonen</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Pre-pregnancy overweight or obesity and gestational diabetes as predictors of body composition in offspring twenty years later-evidence from two birth cohort studies</article-title>. <source>Int. J. Obesit</source>
<pub-id pub-id-type="doi">10.1038/ijo.2017.277</pub-id>, <pub-id pub-id-type="pmid">29146992</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>A.</given-names></name>, <name><surname>Ferrara</surname><given-names>A.</given-names></name>, <name><surname>Windham</surname><given-names>G.C.</given-names></name>, <name><surname>Greenspan</surname><given-names>L.C.</given-names></name>, <name><surname>Deardorff</surname><given-names>J.</given-names></name>, <name><surname>Hiatt</surname><given-names>R.A.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Maternal hyperglycemia during pregnancy predicts adiposity of the offspring</article-title>. <source>Diabetes Care</source>
<volume>37</volume>, <fpage>2996</fpage>&#x02013;<lpage>3002</lpage>
<pub-id pub-id-type="doi">10.2337/dc14-1438</pub-id>
<pub-id pub-id-type="pmid">25150158</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozkurt</surname><given-names>L.</given-names></name>, <name><surname>Gobl</surname><given-names>C.S.</given-names></name>, <name><surname>Rami-Merhar</surname><given-names>B.</given-names></name>, <name><surname>Winhofer</surname><given-names>Y.</given-names></name>, <name><surname>Baumgartner-Parzer</surname><given-names>S.</given-names></name>, <name><surname>Schober</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2016</year>) <article-title>The cross-link between adipokines, insulin resistance and obesity in offspring of diabetic pregnancies</article-title>. <source>Hormone Res. Paediatrics</source>
<volume>86</volume>, <fpage>300</fpage>&#x02013;<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1159/000448076</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><collab>American Diabetes Association</collab> (<year>2018</year>) <article-title>Management of diabetes in pregnancy: standards of medical care in diabetes-2018</article-title>. <source>Diabetes Care</source>
<volume>41</volume>, <fpage>S137</fpage>&#x02013;<lpage>S143</lpage>
<pub-id pub-id-type="doi">10.2337/dc18-S013</pub-id>
<pub-id pub-id-type="pmid">29222384</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabelea</surname><given-names>D.</given-names></name>, <name><surname>Hanson</surname><given-names>R.L.</given-names></name>, <name><surname>Lindsay</surname><given-names>R.S.</given-names></name>, <name><surname>Pettitt</surname><given-names>D.J.</given-names></name>, <name><surname>Imperatore</surname><given-names>G.</given-names></name>, <name><surname>Gabir</surname><given-names>M.M.</given-names></name><etal/></person-group> (<year>2000</year>) <article-title>Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships</article-title>. <source>Diabetes</source>
<volume>49</volume>, <fpage>2208</fpage>&#x02013;<lpage>2211</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.49.12.2208</pub-id>
<pub-id pub-id-type="pmid">11118027</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindell</surname><given-names>N.</given-names></name>, <name><surname>Carlsson</surname><given-names>A.</given-names></name>, <name><surname>Josefsson</surname><given-names>A.</given-names></name> and <name><surname>Samuelsson</surname><given-names>U.</given-names></name></person-group> (<year>2018</year>) <article-title>Maternal obesity as a risk factor for early childhood type 1 diabetes: a nationwide, prospective, population-based case-control study</article-title>. <source>Diabetologia</source>
<volume>61</volume>, <fpage>130</fpage>&#x02013;<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-017-4481-2</pub-id>
<pub-id pub-id-type="pmid">29098322</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Bernardo</surname><given-names>S.</given-names></name>, <name><surname>Mivelaz</surname><given-names>Y.</given-names></name>, <name><surname>Epure</surname><given-names>A.M.</given-names></name>, <name><surname>Vial</surname><given-names>Y.</given-names></name>, <name><surname>Simeoni</surname><given-names>U.</given-names></name>, <name><surname>Bovet</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Assessing the consequences of gestational diabetes mellitus on offspring&#x02019;s cardiovascular health: Mysweetheart cohort study protocol, switzerland</article-title>. <source>BMJ Open</source>
<volume>7</volume>, <fpage>e016972</fpage>
<pub-id pub-id-type="pmid">29138200</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>G.A.</given-names></name>, <name><surname>Singh</surname><given-names>G.M.</given-names></name>, <name><surname>Lu</surname><given-names>Y.</given-names></name>, <name><surname>Danaei</surname><given-names>G.</given-names></name>, <name><surname>Lin</surname><given-names>J.K.</given-names></name>, <name><surname>Finucane</surname><given-names>M.M.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>National, regional, and global trends in adult overweight and obesity prevalences</article-title>. <source>Population Health Metrics</source>
<volume>10</volume>, <fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1478-7954-10-22</pub-id>
<pub-id pub-id-type="pmid">23167948</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>M.S.</given-names></name>, <name><surname>Sparks</surname><given-names>T.N.</given-names></name>, <name><surname>Cheng</surname><given-names>Y.W.</given-names></name> and <name><surname>Caughey</surname><given-names>A.B.</given-names></name></person-group> (<year>2011</year>) <article-title>Treating mild gestational diabetes mellitus: A cost-effectiveness analysis</article-title>. <source>Am. J. Obstet. Gynecol.</source>
<volume>205</volume>, <fpage>282.e281</fpage>&#x02013;<lpage>287.e281</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2011.06.051</pub-id><pub-id pub-id-type="pmid">22071065</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>C.H.</given-names></name>, <name><surname>Weisman</surname><given-names>C.S.</given-names></name>, <name><surname>Hillemeier</surname><given-names>M.M.</given-names></name>, <name><surname>Schwarz</surname><given-names>E.B.</given-names></name>, <name><surname>Camacho</surname><given-names>F.T.</given-names></name> and <name><surname>Dyer</surname><given-names>A.M.</given-names></name></person-group> (<year>2010</year>) <article-title>Pregnancy intention and health behaviors: Results from the central pennsylvania women&#x02019;s health study cohort</article-title>. <source>Matern. Child Health J.</source>
<volume>14</volume>, <fpage>501</fpage>&#x02013;<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1007/s10995-009-0453-6</pub-id>
<pub-id pub-id-type="pmid">19214724</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogozinska</surname><given-names>E.</given-names></name>, <name><surname>Marlin</surname><given-names>N.</given-names></name>, <name><surname>Jackson</surname><given-names>L.</given-names></name>, <name><surname>Rayanagoudar</surname><given-names>G.</given-names></name>, <name><surname>Ruifrok</surname><given-names>A.E.</given-names></name>, <name><surname>Dodds</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Effects of antenatal diet and physical activity on maternal and fetal outcomes: individual patient data meta-analysis and health economic evaluation</article-title>. <source>Health Technol. Assess.</source>
<volume>21</volume>, <fpage>1</fpage>&#x02013;<lpage>158</lpage>
<pub-id pub-id-type="doi">10.3310/hta21410</pub-id>
<pub-id pub-id-type="pmid">28795682</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poston</surname><given-names>L.</given-names></name>, <name><surname>Bell</surname><given-names>R.</given-names></name>, <name><surname>Croker</surname><given-names>H.</given-names></name>, <name><surname>Flynn</surname><given-names>A.C.</given-names></name>, <name><surname>Godfrey</surname><given-names>K.M.</given-names></name>, <name><surname>Goff</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2015</year>) <article-title>Effect of a behavioural intervention in obese pregnant women (the upbeat study): a multicentre, randomised controlled trial</article-title>. <source>Lancet Diabetes Endocrinol.</source>
<volume>3</volume>, <fpage>767</fpage>&#x02013;<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-8587(15)00227-2</pub-id><pub-id pub-id-type="pmid">26165396</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S.</given-names></name>, <name><surname>Middleton</surname><given-names>P.</given-names></name>, <name><surname>Shepherd</surname><given-names>E.</given-names></name>, <name><surname>Van Ryswyk</surname><given-names>E.</given-names></name> and <name><surname>Crowther</surname><given-names>C.A.</given-names></name></person-group> (<year>2017</year>) <article-title>Different types of dietary advice for women with gestational diabetes mellitus</article-title>. <source>Cochrane Database Syst. Rev.</source>
<volume>2</volume>, <fpage>Cd009275</fpage><pub-id pub-id-type="pmid">28236296</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>A.C.</given-names></name>, <name><surname>Dalrymple</surname><given-names>K.</given-names></name>, <name><surname>Barr</surname><given-names>S.</given-names></name>, <name><surname>Poston</surname><given-names>L.</given-names></name>, <name><surname>Goff</surname><given-names>L.M.</given-names></name>, <name><surname>Rogozinska</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2016</year>) <article-title>Dietary interventions in overweight and obese pregnant women: a systematic review of the content, delivery, and outcomes of randomized controlled trials</article-title>. <source>Nutr. Rev.</source>
<volume>74</volume>, <fpage>312</fpage>&#x02013;<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1093/nutrit/nuw005</pub-id>
<pub-id pub-id-type="pmid">27083868</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>H.L.</given-names></name>, <name><surname>Dekker Nitert</surname><given-names>M.</given-names></name>, <name><surname>Conwell</surname><given-names>L.S.</given-names></name> and <name><surname>Callaway</surname><given-names>L.K.</given-names></name></person-group> (<year>2014</year>) <article-title>Probiotics for preventing gestational diabetes</article-title>. <source>Cochrane Database Syst. Rev.</source>
<volume>2</volume>
<fpage>Cd009951</fpage></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>P.P.</given-names></name>, <name><surname>Jiang</surname><given-names>F.</given-names></name>, <name><surname>Chen</surname><given-names>Y.G.</given-names></name>, <name><surname>Yang</surname><given-names>J.</given-names></name>, <name><surname>Zhang</surname><given-names>K.</given-names></name>, <name><surname>Zhang</surname><given-names>M.X.</given-names></name><etal/></person-group> (<year>2015</year>) <article-title>Traditional chinese medication for cardiovascular disease</article-title>. <source>Nat. Rev. Cardiol.</source>
<volume>12</volume>, <fpage>115</fpage>&#x02013;<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1038/nrcardio.2014.177</pub-id>
<pub-id pub-id-type="pmid">25384847</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>P.</given-names></name>, <name><surname>Jiang</surname><given-names>F.</given-names></name>, <name><surname>Cheng</surname><given-names>J.</given-names></name>, <name><surname>Ma</surname><given-names>L.</given-names></name>, <name><surname>Zhang</surname><given-names>Y.</given-names></name> and <name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>) <article-title>Traditional chinese medicine for cardiovascular disease: Evidence and potential mechanisms</article-title>. <source>J. Am. Coll. Cardiol.</source>
<volume>69</volume>, <fpage>2952</fpage>&#x02013;<lpage>2966</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2017.04.041</pub-id>
<pub-id pub-id-type="pmid">28619197</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>L.Y.</given-names></name> and <name><surname>Tan</surname><given-names>R.X.</given-names></name></person-group> (<year>2015</year>) <article-title>Artemisinin, a miracle of traditional chinese medicine</article-title>. <source>Nat. Prod. Rep.</source>
<volume>32</volume>, <fpage>1617</fpage>&#x02013;<lpage>1621</lpage>
<pub-id pub-id-type="doi">10.1039/C5NP00133A</pub-id>
<pub-id pub-id-type="pmid">26561737</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koehn</surname><given-names>F.E.</given-names></name> and <name><surname>Carter</surname><given-names>G.T.</given-names></name></person-group> (<year>2005</year>) <article-title>The evolving role of natural products in drug discovery</article-title>. <source>Nat. Rev. Drug Discovery</source>
<volume>4</volume>, <fpage>206</fpage>&#x02013;<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1038/nrd1657</pub-id><pub-id pub-id-type="pmid">15729362</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabricant</surname><given-names>D.S.</given-names></name> and <name><surname>Farnsworth</surname><given-names>N.R.</given-names></name></person-group> (<year>2001</year>) <article-title>The value of plants used in traditional medicine for drug discovery</article-title>. <source>Environ. Health Perspect.</source>
<volume>109</volume>, <fpage>69</fpage>&#x02013;<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.01109s169</pub-id>
<pub-id pub-id-type="pmid">11250806</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martel</surname><given-names>J.</given-names></name>, <name><surname>Ojcius</surname><given-names>D.M.</given-names></name>, <name><surname>Chang</surname><given-names>C.J.</given-names></name>, <name><surname>Lin</surname><given-names>C.S.</given-names></name>, <name><surname>Lu</surname><given-names>C.C.</given-names></name>, <name><surname>Ko</surname><given-names>Y.F.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Anti-obesogenic and antidiabetic effects of plants and mushrooms</article-title>. <source>Nat. Rev. Endocrinology</source>
<volume>13</volume>, <fpage>149</fpage>&#x02013;<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1038/nrendo.2016.142</pub-id><pub-id pub-id-type="pmid">27636731</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabavi</surname><given-names>S.F.</given-names></name>, <name><surname>Li</surname><given-names>H.</given-names></name>, <name><surname>Daglia</surname><given-names>M.</given-names></name> and <name><surname>Nabavi</surname><given-names>S.M</given-names></name></person-group> (<year>2014</year>) <article-title>Resveratrol and stroke: from chemistry to medicine</article-title>. <source>Curr. Neurovasc. Res.</source>
<volume>11</volume>, <fpage>390</fpage>&#x02013;<lpage>397</lpage>
<pub-id pub-id-type="doi">10.2174/1567202611666140912114833</pub-id><pub-id pub-id-type="pmid">25219659</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>A.L.B.</given-names></name>, <name><surname>Monteiro</surname><given-names>V.V.S.</given-names></name>, <name><surname>Navegantes-Lima</surname><given-names>K.C.</given-names></name>, <name><surname>Reis</surname><given-names>J.F.</given-names></name>, <name><surname>Gomes</surname><given-names>R.S.</given-names></name>, <name><surname>Rodrigues</surname><given-names>D.V.S.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Resveratrol role in autoimmune disease-a mini-review</article-title>. <source>Nutrients</source>
<volume>9</volume>, <fpage>1</fpage>&#x02013;<lpage>22</lpage>, <pub-id pub-id-type="doi">10.3390/nu9121306</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>V.L.</given-names></name>, <name><surname>Jun</surname><given-names>M.</given-names></name> and <name><surname>Jeong</surname><given-names>W.S.</given-names></name></person-group> (<year>2017</year>) <article-title>Role of resveratrol in regulation of cellular defense systems against oxidative stress</article-title>. <source>Biofactors</source>, <volume>44</volume>, <fpage>36</fpage>&#x02013;<lpage>49</lpage>
<pub-id pub-id-type="pmid">29193412</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farzaei</surname><given-names>M.H.</given-names></name>, <name><surname>Bahramsoltani</surname><given-names>R.</given-names></name> and <name><surname>Rahimi</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>) <article-title>Phytochemicals as adjunctive with conventional anticancer therapies</article-title>. <source>Curr. Pharm. Des.</source>
<volume>22</volume>, <fpage>4201</fpage>&#x02013;<lpage>4218</lpage>
<pub-id pub-id-type="doi">10.2174/1381612822666160601100823</pub-id>
<pub-id pub-id-type="pmid">27262332</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.J.</given-names></name>, <name><surname>Ahmad</surname><given-names>F.</given-names></name>, <name><surname>Philp</surname><given-names>A.</given-names></name>, <name><surname>Baar</surname><given-names>K.</given-names></name>, <name><surname>Williams</surname><given-names>T.</given-names></name>, <name><surname>Luo</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting camp phosphodiesterases</article-title>. <source>Cell</source>
<volume>148</volume>, <fpage>421</fpage>&#x02013;<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.01.017</pub-id>
<pub-id pub-id-type="pmid">22304913</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>E.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, <name><surname>Jiang</surname><given-names>S.</given-names></name> and <name><surname>Bai</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>) <article-title>Beneficial effects of resveratrol on atherosclerosis</article-title>. <source>J. Med. Food</source>
<volume>11</volume>, <fpage>610</fpage>&#x02013;<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1089/jmf.2007.0091</pub-id>
<pub-id pub-id-type="pmid">19053850</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name>, <name><surname>Wu</surname><given-names>C.</given-names></name>, <name><surname>Qiu</surname><given-names>S.</given-names></name>, <name><surname>Yuan</surname><given-names>X.</given-names></name> and <name><surname>Li</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>) <article-title>Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: Systematic review and meta-analysis</article-title>. <source>Nutr. Metab.</source>
<volume>14</volume>, <fpage>60</fpage>
<pub-id pub-id-type="doi">10.1186/s12986-017-0217-z</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name>, <name><surname>Chen</surname><given-names>G.</given-names></name>, <name><surname>Liao</surname><given-names>D.</given-names></name>, <name><surname>Zhu</surname><given-names>Y.</given-names></name>, <name><surname>Pu</surname><given-names>R.</given-names></name> and <name><surname>Xue</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>) <article-title>The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: A pooled analysis of randomized controlled trials</article-title>. <source>Obesity Rev.</source>
<volume>17</volume>, <fpage>1329</fpage>&#x02013;<lpage>1340</lpage>
<pub-id pub-id-type="doi">10.1111/obr.12458</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottart</surname><given-names>C.H.</given-names></name>, <name><surname>Nivet-Antoine</surname><given-names>V.</given-names></name>, <name><surname>Laguillier-Morizot</surname><given-names>C.</given-names></name> and <name><surname>Beaudeux</surname><given-names>J.L.</given-names></name></person-group> (<year>2010</year>) <article-title>Resveratrol bioavailability and toxicity in humans</article-title>. <source>Mol. Nutr. Food Res.</source>
<volume>54</volume>, <fpage>7</fpage>&#x02013;<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1002/mnfr.200900437</pub-id><pub-id pub-id-type="pmid">20013887</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>C.K.</given-names></name>, <name><surname>Kumar</surname><given-names>A.</given-names></name>, <name><surname>Lavoie</surname><given-names>H.A.</given-names></name>, <name><surname>Dipette</surname><given-names>D.J.</given-names></name> and <name><surname>Singh</surname><given-names>U.S.</given-names></name></person-group> (<year>2013</year>) <article-title>Diabetic complications in pregnancy: is resveratrol a solution?</article-title>
<source>Exp. Biol. Med.</source>
<volume>238</volume>, <fpage>482</fpage>&#x02013;<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1177/1535370212473704</pub-id>
<pub-id pub-id-type="pmid">23436883</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malvasi</surname><given-names>A.</given-names></name>, <name><surname>Kosmas</surname><given-names>I.</given-names></name>, <name><surname>Mynbaev</surname><given-names>O.A.</given-names></name>, <name><surname>Sparic</surname><given-names>R.</given-names></name>, <name><surname>Gustapane</surname><given-names>S.</given-names></name>, <name><surname>Guido</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients?</article-title>
<source>Clin. Ther.</source>
<volume>168</volume>, <fpage>e240</fpage>&#x02013;<lpage>e247</lpage>
<pub-id pub-id-type="pmid">28703838</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>J.</given-names></name>, <name><surname>Kang</surname><given-names>Y.</given-names></name>, <name><surname>Fan</surname><given-names>Y.</given-names></name> and <name><surname>Chen</surname><given-names>Q.</given-names></name></person-group> (<year>2017</year>) <article-title>Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia</article-title>. <source>Endocr. Connect.</source>
<volume>6</volume>, <fpage>595</fpage>&#x02013;<lpage>600</lpage>
<pub-id pub-id-type="doi">10.1530/EC-17-0130</pub-id>
<pub-id pub-id-type="pmid">28993436</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>V.H.</given-names></name>, <name><surname>Pound</surname><given-names>L.D.</given-names></name>, <name><surname>Thorn</surname><given-names>S.R.</given-names></name>, <name><surname>Gillingham</surname><given-names>M.B.</given-names></name>, <name><surname>Thornburg</surname><given-names>K.L.</given-names></name>, <name><surname>Friedman</surname><given-names>J.E.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates</article-title>. <source>FASEB J.</source>
<volume>28</volume>, <fpage>2466</fpage>&#x02013;<lpage>2477</lpage>
<pub-id pub-id-type="doi">10.1096/fj.13-245472</pub-id><pub-id pub-id-type="pmid">24563374</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L.</given-names></name>, <name><surname>Wan</surname><given-names>J.</given-names></name>, <name><surname>Li</surname><given-names>H.</given-names></name>, <name><surname>Ding</surname><given-names>J.</given-names></name>, <name><surname>Wang</surname><given-names>Y.</given-names></name>, <name><surname>Wang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2015</year>) <article-title>Resveratrol relieves gestational diabetes mellitus in mice through activating ampk</article-title>. <source>Reprod. Biol. Endocrinol.</source>
<volume>13</volume>, <fpage>118</fpage>
<pub-id pub-id-type="doi">10.1186/s12958-015-0114-0</pub-id><pub-id pub-id-type="pmid">26542478</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappas</surname><given-names>M.</given-names></name>, <name><surname>Mitton</surname><given-names>A.</given-names></name>, <name><surname>Lim</surname><given-names>R.</given-names></name>, <name><surname>Barker</surname><given-names>G.</given-names></name>, <name><surname>Riley</surname><given-names>C.</given-names></name> and <name><surname>Permezel</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>) <article-title>Sirt1 is a novel regulator of key pathways of human labor</article-title>. <source>Biol. Reprod.</source>
<volume>84</volume>, <fpage>167</fpage>&#x02013;<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1095/biolreprod.110.086983</pub-id>
<pub-id pub-id-type="pmid">20844277</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>H.T.</given-names></name>, <name><surname>Liong</surname><given-names>S.</given-names></name>, <name><surname>Lim</surname><given-names>R.</given-names></name>, <name><surname>Barker</surname><given-names>G.</given-names></name> and <name><surname>Lappas</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>) <article-title>Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle</article-title>. <source>PLoS One</source>
<volume>12</volume>, <fpage>e0173373</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0173373</pub-id>
<pub-id pub-id-type="pmid">28278187</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>T.</given-names></name>, <name><surname>Chen</surname><given-names>D.</given-names></name>, <name><surname>Yang</surname><given-names>Q.</given-names></name>, <name><surname>Wang</surname><given-names>B.</given-names></name>, <name><surname>Zhu</surname><given-names>M.J.</given-names></name>, <name><surname>Nathanielsz</surname><given-names>P.W.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Resveratrol supplementation of high-fat diet-fed pregnant mice promotes brown and beige adipocyte development and prevents obesity in male offspring</article-title>. <source>J. Physiol.</source>
<volume>595</volume>, <fpage>1547</fpage>&#x02013;<lpage>1562</lpage>
<pub-id pub-id-type="doi">10.1113/JP273478</pub-id>
<pub-id pub-id-type="pmid">27891610</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ros</surname><given-names>P.</given-names></name>, <name><surname>Diaz</surname><given-names>F.</given-names></name>, <name><surname>Freire-Regatillo</surname><given-names>A.</given-names></name>, <name><surname>Argente-Arizon</surname><given-names>P.</given-names></name>, <name><surname>Barrios</surname><given-names>V.</given-names></name>, <name><surname>Argente</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Resveratrol intake during pregnancy and lactation modulates the early metabolic effects of maternal nutrition differently in male and female offspring</article-title>. <source>Endocrinology</source>, <volume>59</volume>, <fpage>810</fpage>&#x02013;<lpage>825</lpage>, <pub-id pub-id-type="doi">10.1210/en.2017-00610</pub-id>, <pub-id pub-id-type="pmid">29186387</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>J.G.</given-names></name>, <name><surname>Dias-Rocha</surname><given-names>C.P.</given-names></name>, <name><surname>Fernandes</surname><given-names>T.P.</given-names></name>, <name><surname>Albuquerque Maia</surname><given-names>L.</given-names></name>, <name><surname>Lisboa</surname><given-names>P.C.</given-names></name>, <name><surname>Moura</surname><given-names>E.G.</given-names></name><etal/></person-group> (<year>2016</year>) <article-title>Resveratrol treatment rescues hyperleptinemia and improves hypothalamic leptin signaling programmed by maternal high-fat diet in rats</article-title>. <source>Eur. J. Nutr.</source>
<volume>55</volume>, <fpage>601</fpage>&#x02013;<lpage>610</lpage>
<pub-id pub-id-type="doi">10.1007/s00394-015-0880-7</pub-id>
<pub-id pub-id-type="pmid">25801629</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>C.K.</given-names></name>, <name><surname>Kumar</surname><given-names>A.</given-names></name>, <name><surname>Hitchcock</surname><given-names>D.B.</given-names></name>, <name><surname>Fan</surname><given-names>D.</given-names></name>, <name><surname>Goodwin</surname><given-names>R.</given-names></name>, <name><surname>LaVoie</surname><given-names>H.A.</given-names></name><etal/></person-group> (<year>2011</year>) <article-title>Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam</article-title>. <source>Mol. Nutr. Food Res.</source>
<volume>55</volume>, <fpage>1186</fpage>&#x02013;<lpage>1196</lpage>
<pub-id pub-id-type="doi">10.1002/mnfr.201000457</pub-id><pub-id pub-id-type="pmid">21254394</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Care</surname><given-names>A.S.</given-names></name>, <name><surname>Sung</surname><given-names>M.M.</given-names></name>, <name><surname>Panahi</surname><given-names>S.</given-names></name>, <name><surname>Gragasin</surname><given-names>F.S.</given-names></name>, <name><surname>Dyck</surname><given-names>J.R.</given-names></name>, <name><surname>Davidge</surname><given-names>S.T.</given-names></name><etal/></person-group> (<year>2016</year>) <article-title>Perinatal resveratrol supplementation to spontaneously hypertensive rat dams mitigates the development of hypertension in adult offspring</article-title>. <source>Hypertension</source>
<volume>67</volume>, <fpage>1038</fpage>&#x02013;<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.115.06793</pub-id>
<pub-id pub-id-type="pmid">26928803</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraloglu</surname><given-names>O.</given-names></name>, <name><surname>Engin-Ustun</surname><given-names>Y.</given-names></name>, <name><surname>Tonguc</surname><given-names>E.</given-names></name>, <name><surname>Var</surname><given-names>T.</given-names></name>, <name><surname>Tapisiz</surname><given-names>O.L.</given-names></name>, <name><surname>Ergun</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>) <article-title>The effect of resveratrol on blood pressure in a rat model of preeclampsia</article-title>. <source>J. Matern. Fetal Neonatal Med.</source>
<volume>25</volume>, <fpage>845</fpage>&#x02013;<lpage>848</lpage>
<pub-id pub-id-type="doi">10.3109/14767058.2011.599081</pub-id><pub-id pub-id-type="pmid">21848411</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>A.</given-names></name>, <name><surname>Reyes</surname><given-names>L.M.</given-names></name>, <name><surname>Morton</surname><given-names>J.S.</given-names></name>, <name><surname>Fung</surname><given-names>D.</given-names></name>, <name><surname>Schneider</surname><given-names>J.</given-names></name> and <name><surname>Davidge</surname><given-names>S.T.</given-names></name></person-group> (<year>2016</year>) <article-title>Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet</article-title>. <source>J. Physiol.</source>
<volume>594</volume>, <fpage>1465</fpage>&#x02013;<lpage>1482</lpage>
<pub-id pub-id-type="doi">10.1113/JP271133</pub-id>
<pub-id pub-id-type="pmid">26467260</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klink</surname><given-names>J.C.</given-names></name>, <name><surname>Tewari</surname><given-names>A.K.</given-names></name>, <name><surname>Masko</surname><given-names>E.M.</given-names></name>, <name><surname>Antonelli</surname><given-names>J.</given-names></name>, <name><surname>Febbo</surname><given-names>P.G.</given-names></name>, <name><surname>Cohen</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2013</year>) <article-title>Resveratrol worsens survival in scid mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways</article-title>. <source>Prostate</source>
<volume>73</volume>, <fpage>754</fpage>&#x02013;<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1002/pros.22619</pub-id>
<pub-id pub-id-type="pmid">23192356</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Silva</surname><given-names>J.H.</given-names></name>, <name><surname>Simoes-Alves</surname><given-names>A.C.</given-names></name> and <name><surname>Fernandes</surname><given-names>M.P.</given-names></name></person-group> (<year>2016</year>) <article-title>Developmental origins of cardiometabolic diseases: Role of the maternal diet</article-title>. <source>Front. Physiol.</source>
<volume>7</volume>, <fpage>504</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2016.00504</pub-id><pub-id pub-id-type="pmid">27899895</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estampador</surname><given-names>A.C.</given-names></name> and <name><surname>Franks</surname><given-names>P.W.</given-names></name></person-group> (<year>2014</year>) <article-title>Genetic and epigenetic catalysts in early-life programming of adult cardiometabolic disorders</article-title>. <source>Diabetes Metab. Syndr. Obes.</source>
<volume>7</volume>, <fpage>575</fpage>&#x02013;<lpage>586</lpage>
<pub-id pub-id-type="pmid">25489250</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J.</given-names></name>, <name><surname>Xiao</surname><given-names>X.</given-names></name>, <name><surname>Zhang</surname><given-names>Q.</given-names></name> and <name><surname>Yu</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>) <article-title>DNA methylation: the pivotal interaction between early-life nutrition and glucose metabolism in later life</article-title>. <source>Br. J. Nutr.</source>
<volume>112</volume>, <fpage>1850</fpage>&#x02013;<lpage>1857</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114514002827</pub-id>
<pub-id pub-id-type="pmid">25327140</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J.</given-names></name>, <name><surname>Xiao</surname><given-names>X.</given-names></name>, <name><surname>Zhang</surname><given-names>Q.</given-names></name>, <name><surname>Wang</surname><given-names>T.</given-names></name>, <name><surname>Yu</surname><given-names>M.</given-names></name> and <name><surname>Xu</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>) <article-title>Maternal low-protein diet modulates glucose metabolism and hepatic micrornas expression in the early life of offspring dagger</article-title>. <source>Nutrients</source>
<volume>9</volume>, <fpage>1</fpage>&#x02013;<lpage>14</lpage>, <pub-id pub-id-type="doi">10.3390/nu9030205</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J.</given-names></name>, <name><surname>Zhang</surname><given-names>Q.</given-names></name>, <name><surname>Mul</surname><given-names>J.D.</given-names></name>, <name><surname>Yu</surname><given-names>M.</given-names></name>, <name><surname>Xu</surname><given-names>J.</given-names></name>, <name><surname>Qi</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2016</year>) <article-title>Maternal high-calorie diet is associated with altered hepatic microrna expression and impaired metabolic health in offspring at weaning age</article-title>. <source>Endocrine</source>
<volume>54</volume>, <fpage>70</fpage>&#x02013;<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1007/s12020-016-0959-9</pub-id>
<pub-id pub-id-type="pmid">27106801</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>X.</given-names></name> and <name><surname>Zheng</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>) <article-title>Micrornas: Crucial modulators of fetal epigenetic programming in nutrition and glucose metabolism</article-title>. <source>Chin. Med. J.</source>
<volume>127</volume>, <fpage>3521</fpage>&#x02013;<lpage>3523</lpage>
<pub-id pub-id-type="pmid">25316222</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamkova</surname><given-names>K.</given-names></name>, <name><surname>Yi</surname><given-names>Y.J.</given-names></name>, <name><surname>Petr</surname><given-names>J.</given-names></name>, <name><surname>Zalmanova</surname><given-names>T.</given-names></name>, <name><surname>Hoskova</surname><given-names>K.</given-names></name>, <name><surname>Jelinkova</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>) <article-title>Sirt1-dependent modulation of methylation and acetylation of histone h3 on lysine 9 (h3k9) in the zygotic pronuclei improves porcine embryo development</article-title>. <source>J. Anim. Sci. Biotechnol.</source>
<volume>8</volume>, <fpage>83</fpage>
<pub-id pub-id-type="doi">10.1186/s40104-017-0214-0</pub-id><pub-id pub-id-type="pmid">29118980</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papoutsis</surname><given-names>A.J.</given-names></name>, <name><surname>Selmin</surname><given-names>O.I.</given-names></name>, <name><surname>Borg</surname><given-names>J.L.</given-names></name> and <name><surname>Romagnolo</surname><given-names>D.F.</given-names></name></person-group> (<year>2015</year>) <article-title>Gestational exposure to the ahr agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces brca-1 promoter hypermethylation and reduces brca-1 expression in mammary tissue of rat offspring: Preventive effects of resveratrol</article-title>. <source>Mol. Carcinog.</source>
<volume>54</volume>, <fpage>261</fpage>&#x02013;<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1002/mc.22095</pub-id>
<pub-id pub-id-type="pmid">24136580</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protic</surname><given-names>D.</given-names></name>, <name><surname>Beleslin-Cokic</surname><given-names>B.</given-names></name>, <name><surname>Spremovic-Radenovic</surname><given-names>S.</given-names></name>, <name><surname>Radunovic</surname><given-names>N.</given-names></name>, <name><surname>Heinle</surname><given-names>H.</given-names></name>, <name><surname>Scepanovic</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>) <article-title>The different effects of resveratrol and naringenin on isolated human umbilical vein: The role of atp-sensitive k(+) channels</article-title>. <source>Phytother. Res.</source>
<volume>28</volume>, <fpage>1412</fpage>&#x02013;<lpage>1418</lpage>
<pub-id pub-id-type="doi">10.1002/ptr.5145</pub-id><pub-id pub-id-type="pmid">24638940</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>J.Y.</given-names></name>, <name><surname>Park</surname><given-names>D.</given-names></name>, <name><surname>Shin</surname><given-names>S.</given-names></name>, <name><surname>Jeon</surname><given-names>J.H.</given-names></name>, <name><surname>Choi</surname><given-names>B.I.</given-names></name>, <name><surname>Joo</surname><given-names>S.S.</given-names></name><etal/></person-group> (<year>2008</year>) <article-title>Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin</article-title>. <source>Eur. J. Pharmacol.</source>
<volume>591</volume>, <fpage>280</fpage>&#x02013;<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2008.05.033</pub-id>
<pub-id pub-id-type="pmid">18571640</pub-id></mixed-citation></ref></ref-list></back></article>